Preclinical evaluation of long-acting cabotegravir and rilpivirine for HIV post-exposure prophylaxis in a macaque model

Authors

Frank Deyounks
Jose Gerardo Garcia-Lerma (ORCID: https://orcid.org/0000-0001-6437-7745)
Tiancheng Edwards
Dawn Little (ORCID: https://orcid.org/0000-0002-8066-8988)
Walid Heneine (ORCID: https://orcid.org/0000-0003-3119-3565)
Tyana Singletary
Jining Zhang (ORCID: https://orcid.org/0000-0001-9745-7047)
Athena P. Kourtis (ORCID: https://orcid.org/0000-0003-1585-1310)
Maria Mendoza (ORCID: https://orcid.org/0000-0003-1755-394X)
Yi Pan (ORCID: https://orcid.org/0000-0003-1978-475X)
A. J. E. Green
Priya Srinivasan (ORCID: https://orcid.org/0000-0001-8426-6532)
James M. Smith (ORCID: https://orcid.org/0000-0003-0262-8195)
Ryan Johnson
Jonathan Lipscomb
Chuong Dinh

Institutions

Centers for Disease Control and Prevention (US)
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
Gannett (United States) (US)
Care Resource (US)

Publication Details

Journal: EBioMedicine
Published: 2025-12-09
DOI: https://doi.org/10.1016/j.ebiom.2025.106067
Primary Topic: HIV/AIDS drug development and treatment
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Centers for Disease Control and Prevention

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Preclinical evaluation of long-acting cabotegravir and rilpivirine for HIV post-exposure prophylaxis in a macaque model

Frank Deyounks, Jose Gerardo Garcia-Lerma, Tiancheng Edwards, Dawn Little et al.

Dec 9, 2025

EBioMedicine

HIV/AIDS drug development and treatment

article

Preclinical evaluation of long-acting cabotegravir and rilpivirine for HIV post-exposure prophylaxis in a macaque model

Frank Deyounks, Jose Gerardo Garcia-Lerma, Tiancheng Edwards, Dawn Little, Walid Heneine, Tyana Singletary, Jining Zhang, Athena P. Kourtis, Maria Mendoza, Yi Pan, A. J. E. Green, Priya Srinivasan, James M. Smith, Ryan Johnson, Jonathan Lipscomb, Chuong Dinh

December 9, 2025article en

Abstract

No abstract available for this paper.

EBioMedicineVol. 123

Centers for Disease Control and Prevention (US), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US), Gannett (United States) (US), Care Resource (US)

Centers for Disease Control and Prevention

Openalex Percentile: Top 53%

HIV/AIDS drug development and treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Preclinical evaluation of long-acting cabotegravir and rilpivirine for HIV post-exposure prophylaxis in a macaque model — Frank Deyounks, Jose Gerardo Garcia-Lerma, et al. · EBioMedicine (2025) | TGRS Research Map | TGRS